ArticleActa Cardiologica Sinica2018

Low Dose Spironolactone Monotherapy in the Management of Stage I Essential Hypertension: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial.

Armin Attar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.